期刊文献+

全程加速超分割治疗局部晚期上颌窦癌的疗效分析 被引量:1

Clinical analysis on the effect of local advanced maxillary sinus carcinoma patients treated by whole course accelerated hyperfractionated radiotherapy
下载PDF
导出
摘要 目的:评价全程加速超分割治疗局部晚期不能手术的上颌窦癌的疗效及预后。方法:1996年3月-2004年3月收住71例局部晚期不能手术的上颌窦癌患者,随机分为两组。(1)全程加速超分割组(CAHF)36例;每周5d,每天2次,每次1.5Gy,间隔时间6h以上,总量DT66-70Gy/44-46 f/32-34d;(2)常规分割照射组(CF)35例,5次/w,1次/d,每次2.0Gy,总量DT66-80Gy/33-35 f/44-46d。结果:常规照射组和全程超分割组1,2,3,4,5年的局控率分别为62.8%,34.3%,22.9%,14.3%,5.7%和88.6%,66.7%,52.8%,36.3%,25%(P〈0.05);常规照射和全程加速超分割组1,2,3,4,5年的生存率分别为6 5.7%,4 5.7%,2 8.6%,2 2.8%,1 6%和9 4.4%,7 2.2%,5 8.3%,5 7.2%,3 6.1%(P〈0.0 5),加速超分割组较常规分割组高,两组的晚期并发症及死亡原因无明显差异。结论:全程加速超分割放射治疗对不能手术的晚期上颌窦癌患者,能明显提高局控率和生存率,但口腔粘膜反应较常规分割组增高,但可耐受。 Objective: To evaluate the result of local advanced maxillary sinus carcinoma patients treated with whole course accelerated hyperfractionated radiotherapy(CAHF) . Methods: From March 1996 - March 2004,71 patients of local advanced maxillary sinus carcinoma were divided randomly into two groups: ( 1 ) CAHF group, 36 pa- tients were treated by whole course accelerated hyperfractionated radiotherapy. Radical tumoricidal dose of 75 - 80 Gy was delivered in 50 -54 fractions over 51 - 56 days ( 1.5 Gy/d, twice, a 6 hour interval). ( 2 ) CF ( conventional frac- tionated radiotherapy) group, 35 patients were conventional fractionated radiotherapy ( DT60 - 70Gy/33 -35f/44 - 51d). Results: 1,2,3,4 and 5 - year local control rates were 88.6% ,66.7%, 52.8% ,36.3% ,25% ;and 62.8%, 34.3% ,22.9%, 14.3% ,25.0% ;in CAHF and CF groups,respectively. 1,2,3,4 and 5 -year survival rates were 94.4% ,72.2% ,58.3% ,57.2% ,36.1% and 65.7% ,45.7% ,28.6% ,22.8% , 16% in CAHF and CF group respectively . The oral cavity acute side effect in CAHF group were more severe than those at CF group. But the patients could bear radioreaction in CAHF . Conclusion: Whole course accelerated hyperfractionated radiotherapy can be taken as a effective treatment for local advanced maxillary sinus carcinoma . It can improve local control rate and survival rate .
出处 《现代肿瘤医学》 CAS 2007年第5期624-626,共3页 Journal of Modern Oncology
关键词 上颌窦癌 放射疗法 放射剂量分次 预后 maxillary sinus neoplasm radiotherapy dose fractionation prognosis
  • 相关文献

参考文献4

  • 1S K ladowskik.Randomized clinicaltrial on 7-day continuous irradiation of head and neck cancer-report on 3-year tumour control normal tissue toxicity[J].Radither 0ncol,2000,55:101-110.
  • 2Overggaaard Sand-hansen H.Conventional radiotherapy as primary treatment of squmous cell caroinoma of the head and neck a randomized multicenter study of 5 versus 6 fraction per week-report from the DAHANCA 7 trial[J].Radiat Oncol Phys,1997,39 supp1:188.
  • 3S K ladowskik,Maciejewski.Randomized clinical trial on 7-day -condition accelerated irradiation of head and neck cancer-report on 3 -year tumor control and normal tissue toxicity[J].Radiather Oncol,2000,55:101-110.
  • 4Lee Awm,Sze WM.Retrospective analysis on treating nasopharyngeal carcinoma with accelerated hyperfractionation in compare with cnventional fractionation report on 3-year tumor control and normal tissue toxicity[J].Radiather Oncol,2001,58:121-130.

同被引文献11

  • 1Mesia R,Manos M,Nogues J,et al. Hyperfractionatedradiotherapy:improvement of survival in locally advancednasopharyngeal carcinoma [J]]. Ann Otol Rhinol Laryn-gol,2009,118(6):442-448.
  • 2Lindholm P,Valavaara R,Aitasalo K,et al. Preoperativehyperfractionated accelerated radiotherapy and radical surgeryin advanced head and neck cancer:a prospective phase Hstudy[J]. Radiother Oncol,2006,78(2):146-151.
  • 3Turner J H,Reh D D. Incidence and survival in patientswith sinonasal cancer:a historical analysis of population-based data[J]. Head Neck,2012,34(6):877-885.
  • 4Mendenhall W M,Amdur R J,Morris C G,et al. Carci-noma of the nasal cavity and paranasal sinuses[J]. Laryn-goscope,2009,119(5):899-906.
  • 5Wiegner E A,Daly M E,Murphy J D,et al. Intensity-modulated radiotherapy for tumors of the nasal cavity andparanasal sinuses:clinical outcomes and patterns of fail-ure[J]. Int J Radiat Oncol Biol Phys,2012,83(1):243-251.
  • 6Bourhis J,Overgaard J,Audry H,et al. Hyperfraction-ated or accelerated radiotherapy in head and neck cancer:a meta-analysis[J],Lancet,2006,368(9538):843-854.
  • 7Fu K K,Pajak T F,Trotti A,et al. A Radiation Thera-py Oncology Group(RTOG) phase Ⅲ randomized studyto compare hyperfractionation and two variants of acceler-ated fractionation to standard fractionation radiotherapyfor head and neck squamous cell carcinomas:first reportof RTOG 9003[J]. Int J Radiat Oncol Biol Phys,2000,48(1):7-16.
  • 8Kang J H,Cho S H,Kim J P,et ai. Treatment out-comes between concurrent chemoradiotherapy and com-bination of surgery,radiotherapy,and/or chemotherapyin stage Ⅲ and IV maxillary sinus cancer:multi-institu-tional retrospective analysis[J].J Oral Maxillofac Surg,2012,70(7):1717-1723.
  • 9Monroe A T,Bhandare N,Morris C G,et al. Preven-ting radiation retinopathy with hyperfractionation [ J].Int J Radiat Oncol Biol Phys,2005,61(3):856-864.
  • 10白艳霞,闫利英,陈阳静,宋丽萍,赵瑞敏.序贯性综合治疗上颌窦癌43例临床疗效分析[J].临床耳鼻咽喉头颈外科杂志,2008,22(23):1073-1076. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部